BLANK ROME GOVERNMENT RELATIONS for MYLAN LABORATORIES INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 214, Preserve Access to Affordable Generics Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTI REMINGTON | — |
Health Issues HCR
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE SCONTRAS ANDERSON | — |
| ASHLEY DAVIS | — |
| E PETER GIAMBASTIANI | — |
| J MICHAEL HOGAN | — |
| MALLOY MCDANIEL | — |
| STEPHEN PERANICH | — |
| KRISTI REMINGTON | — |
| SHIMON STEIN | — |
Budget/Appropriations BUD
FY 2014 Appropriations and FY 2013 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY13 Presidential Budget Request
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE SCONTRAS ANDERSON | — |
| ASHLEY DAVIS | — |
| E PETER GIAMBASTIANI | — |
| J MICHAEL HOGAN | — |
| MALLOY MCDANIEL | — |
| STEPHEN PERANICH | — |
| KRISTI REMINGTON | — |
| SHIMON STEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.